References
- Anonymous PhRMA (1998). PhRMA Facts, Washington, DC. Cragg GM, Newman DJ, Snader KM (1997): J Nat Prod 60: 52–60.
- Grifo F, Newman D, Fairfield AS, Bhatacharya B, Grupenhoff JT (1996): The origin of prescription drugs. In Grifo F, Rosenthal J, eds., Biodiversity and Human Health. Wash-ington, DC, Island Press.
- Gupta MP (1995): Panamanian flora: Source of bioactive com-pounds. In: Hostettmann K, Marston A, eds., Phytochem-istry of Plants used in Traditional Medicine. Oxford University Press, pp. 357-398.
- Gupta MP (1998): Programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED), Subprograma X. Quimica Fina Farmacéutica: Logros y perspectivas. Indus-tria Farmacéutica, (Espana) XIII 2: 63–70
- Gupta IVIP, Marston A, Hostettmann K (1999): Panamanian flora as source of bioactive molecules. In: Hostettmann K, Gupta MP, Marston A, eds., Chemistry, Biological and Pharma-cological Properties of Medicinal Plants from the Ameri-cas. Harwood Press, Inc.
- Kursar TA, Capson TL, Coley PD, Corley DG et al. (1999): Ecologically guided bioprospecting in Panama. Pharm Biol 37 (Suppl.): 114–126.
- Nader W, Hill B (1999): Der Schatz in Tropen — Wald: Biodi-versitiit als Inspirations — und Innovations — quelle. Shaker Verlag, Achen, Germany.
- The Economist (1998): The Pharmaceutical Industry Survey, 21–7.
- Ten Kate T, Laird SA (1999): The Commercial use of Biodiver-sity — Access to Genetic Resources and Benefit Sharing. Earth Scan Publications Ltd, London, UK., p. 398.